Search Term:

*


January 16, 2018: Product identified by key industry publication as one of the most exciting commercial drug development and manufacturing technologies, tools or services released during the past year

January 29, 2018: New name reinforces Pall's commitment to providing standard configurable single-use, stainless steel and hybrid technologies for fed-batch and continuous processes across upstream, downstream and formulation and filling applications in biotech

September 11, 2015: Pall manufacturing facility in Ilfracombe, UK is singled out for its exceptional health and safety management systems

October 20, 2015: A total of four new and updated products to be unveiled at the event, with Pall experts on hand to discuss advances that continuously improve bioprocesses for customers

November 9, 2017: New training courses starting early 2018 focused on continuous bioprocessing advances will detail the state of the industry, and the advantages and practical implications of transitioning from batch to semi- or fully-continuous bioprocess methodologies

December 9, 2016: Cadence Acoustic Separator wins the BioProcess International (BPI) Award for best downstream processing application

July 23, 2018: New partnership to integrate novel biologics and biosimilars process know-how and regulatory experience from molecule selection to full commercialization, with efficient upstream and downstream process equipment and facility design solutions for manufacturers

September 11, 2018: Pall and Aetos partner to combine bioreactors, mixing and storage, and downstream technologies with cell lines and manufacturing processes for expedited biosimilars development

April 1, 2021: Major capacity expansion underway to support increase in industry demand

January 7, 2021: Pall Corporation expands production capacity in the United States and Europe to support industry demand

March 31, 2021: New acquisition will help support single-use technology demand driven by COVID-19

March 19, 2019: New lab will serve as a dedicated platform where the industry can access shared resources including equipment, expertise and project work to find innovative solutions to manufacturing needs for biologic medicines, such as cell-based immunotherapies

April 29, 2019: Freeline's (AAV) manufacturing platform and Pall’s iCELLis bioreactor system combine to achieve commercial-scale and high quality production of AAV gene therapy vectors

September 28, 2016: A series of new product launches being planned for Biotech Week Boston in October

June 15, 2015: Announcing Pall's signing of an exclusive license for acoustic wave separation (AWS), a disruptive technology from FloDesign Sonics (FDS) for cell culture clarification for both fed-batch and perfusion applications

October 13, 2016: Introducing a reliable, robust, universal single-use fluid handling connector - a genderless technology for the sterile connection of two fluid paths even in uncontrolled environments

October 5, 2016: Launch of new product designed for linear scale-up of an existing PD-scale continuous purification process to a GMP-compliant process-scale continuous purification using feedstreams derived from fed batch bioreactors of up to 2000 liter volume

March 13, 2019: Pall Biotech to distribute ARTeSYN’s standard hardware and liner components for fluid flow control. Customers to benefit from the flexibility, agility and reliability required for their bioprocessing journey, with accelerated implementation of robust and standardized single-use fluid management and control

September 25, 2017: Announcing three new additions to the Allegro™ single-use chromatography and Cadence™ continuous bioprocessing product portfolios, to be showcased this week at the BPI 2017 event in Boston

October 4, 2016: Multiple breakthrough technologies announced to enable integrated, process-scale continuous production of biotherapies in single-use format